Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hypermethylation

Medical Oncology

Volumn 28, Issue 2, 2011, Pages 420-423

  Sadeq, Vallian ^a   Isar, Nassiri ^a   Manoochehr, Tavassoli ^a  

^a UNIVERSITY OF ISFAHAN   (Iran)

Author keywords

Breast cancer; Iranian population; Promoter hypermethylation; PTEN gene

Indexed keywords

GENOMIC DNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; BREAST CANCER; CANCER GROWTH; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IRAN; PRIORITY JOURNAL;

EID: 85027932610     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9473-8     Document Type: Article

References (21)

1. V Stambolic A Suzuki JL Pompa GM Brothers C Mirtsos T Sasaki J Ruland JM Penninger DP Siderovski TW Mak 1998 Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95 29 39 9778245 10.1016/S0092-8674(00)81780-8 1:CAS:528:DyaK1cXmslWlsr0%3D (Pubitemid 28458022)
2. J Gu M Tamura R Pankov EH Danen T Takino K Matsumoto KM Yamada 1999 Shc and FAK differentially regulate cell motility and directionality modulated by PTEN J Cell Biol 146 389 403 10427092 10.1083/jcb.146.2.389 1:CAS:528: DyaK1MXkvVGmt7c%3D (Pubitemid 29369775)
3. DJ Freeman AG Li G Wei H-H Li N Kertesz R Lesche AD Whale H Martinez-Diaz N Rozengurt RD Cardiff, et al. 2003 PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms Cancer Cell 3 117 130 12620407 10.1016/S1535-6108(03)00021-7 1:CAS:528:DC%2BD3sXhvFyrsro%3D (Pubitemid 37443385)
4. AG Li LG Piluso X Cai G Wei WR Sellers X Liu 2006 Mechanistic insights into maintenance of high p53 acetylation by PTEN Mol Cell 23 575 587 16916644 10.1016/j.molcel.2006.06.028 (Pubitemid 44205492)
5. J Reifenberger M Wolter J Bostrom, et al. 2000 Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas Virchows Arch 436 487 493 10881743 10.1007/s004280050477 1:CAS:528:DC%2BD3cXjtFKmt7Y%3D (Pubitemid 30312165)
6. JH Piekarski W Biernat 2006 Clinical significance of CK5/6 and PTEN protein expression in patients with bilateral breast carcinoma Histopathology 49 248 255 16918971 10.1111/j.1365-2559.2006.02482.x 1:STN:280: DC%2BD28vpsV2ltg%3D%3D (Pubitemid 44253614)
7. Z Li TY Wings LWC Chow 2007 PTEN and VEGF: possible predictors for sentinel lymph node micro-metastasis in breast cancer Biomed Pharmacother 61 558 561 10.1016/j.biopha.2006.11.002 (Pubitemid 46185876)
8. S Mise-Omataa Y Obataa S Iwaseb N Misec T Doia 2005 Transient strong reduction of PTEN expression by specific RNAi induces loss of adhesion of the cells Biochem Biophys Res 38 1034 1042 10.1016/j.bbrc.2005.01.066 (Pubitemid 40238739)
9. V Stambolic MS Tsao D Macpherson A Suzuki WB Chapman TW Mak 2000 High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten±mice Cancer Res 60 13 3605 3611 10910075 1:CAS:528: DC%2BD3cXkvFChsbg%3D (Pubitemid 30482183)
10. I Nassiri M Tavasoli M Faghihi 2008 Pharmacogenomic profiling of the PI3 K/PTEN pathway in sporadic breast cancer Iran Biomed J 12 4 209 214
11. I Nassiri M Tavasoli M Faghihi 2008 Mutational analysis in the MMAC1 gene associated in patients with juvenile polyposis syndrome and cowden fisease Austral Asian J Can 7 3 25 30
12. SN Sehgal H Baker C Vezina 1975 Rapamycin (AY-22, 989), a new antifungal antibiotic. II. Fermentation, isolation and characterization J Antibiot 28 727 732 1102509 1:CAS:528:DyaE28Xis1eqsg%3D%3D
13. C Singer W Köstler G Hudelist 2008 Predicting the efficacy of trastuzumab-based therapy in breast cancer: Current standards and future strategies Biochim Biophys Acta 1786 2 105 13 18375208 1:CAS:528: DC%2BD1cXhtlyhsLjN
14. Sambrook J, Fritsh EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 2001.
15. SA Miller DD Dykes HF Polesky 1988 A simple salting-out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1215 3344216 10.1093/nar/16.3.1215 1:CAS:528:DyaL1cXhsVKlsrs%3D
16. MA Zysman WB Chapman B Bharati 2002 Considerations when analyzing the methylation status of PTEN tumor suppressor gene Am J Pathol 160 795 800 11891178 10.1016/S0002-9440(10)64902-4 1:CAS:528:DC%2BD38XisVemsbk%3D (Pubitemid 34224569)
17. SJ Baker 2007 PTEN enters the nuclear age Cell 128 25 28 17218252 10.1016/j.cell.2006.12.023 1:CAS:528:DC%2BD2sXptl2iuw%3D%3D (Pubitemid 46048899)
18. S Bose A Crane H Hibshoosh M Mansukhani L Sandweis R Parsons 2002 Reduced expression of PTEN correlates with breast cancer progression Hum Pathol 33 405 409 12055674 10.1053/hupa.2002.124721 1:CAS:528:DC%2BD38XltlOksro%3D (Pubitemid 34627590)
19. K Khan K Umagal J Vora N Bose S Sehgal E Koeffler S Bose 2004 PTEN promoter is methylated in a proportion of invasive breast cancer Int J Cancer 112 407 410 15382065 10.1002/ijc.20447 1:CAS:528:DC%2BD2cXovVelsrk%3D (Pubitemid 39390604)
20. Y Kang HS Lee KW Ho 2002 Promoter methylation and silencing of PTEN in gastric carcinoma Lab Invest 82 285 291 11896207 1:CAS:528:DC%2BD38XivFOltr0%3D (Pubitemid 34242522)
21. S Chang SN Lee MS Cho H Koo WS Han SA Im B Moon HS Suh HY Choi S Sung 2005 Loss of PTEN expression in breast cancers Korean J Path 39 236 241